Document Detail


Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation.
MedLine Citation:
PMID:  22023454     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Posttransplant cytopenias are a severe complication after allogeneic stem cell transplantation (allo-SCT) and their origin is often multifactorial or unknown. They are frequently refractory to standard therapy, which may include steroids and/or immunoglobulins. Mesenchymal stem cells (MSCs) are an attractive therapeutic tool in the allo-SCT setting for the ability to enhance engraftment as well as acting as immunosuppressants for graft-versus-host disease. There is no prior experience in the literature of the use of MSCs to treat cytopenias after allo-SCT. CASE REPORTS: In this work we report for the first time four cases of refractory posttransplant cytopenias (three patients with thrombocytopenia and one with neutropenia) that were treated with MSCs from a third-party donor. MSCs were expanded from 100 mL of marrow obtained under standard good manufacturing practice conditions. Most patients received more than one cell dose, and median dose of MSCs administered was 1 × 10(6) /kg. RESULTS: All patients recovered normal blood counts, with a mean follow-up of 12.5 months. There were no adverse events related to MSC administration. CONCLUSION: MSC therapy may contribute to the recovery of refractory posttransplant peripheral cytopenias in patients undergoing allo-SCT.
Authors:
Fermin M Sánchez-Guijo; Olga López-Villar; Lucía López-Anglada; Eva M Villarón; Sandra Muntión; María Díez-Campelo; Jose A Perez-Simón; Jesús F San Miguel; Dolores Caballero; Maria-Consuelo Del Cañizo
Related Documents :
22143354 - Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.
2199174 - Triple labeling with two-color immunofluorescence using one light source: a useful appr...
22262354 - Extramedullary hematopoiesis: a new look at the underlying stem cell niche, theories of...
22252524 - Synergistic effect of scf and g-csf on stem-like properties in prostate cancer cell lines.
18395084 - Direct presentation of antigen by lymph node stromal cells protects against cd8 t-cell-...
15654834 - T cell repertoire in patients with stable scleroderma.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-24
Journal Detail:
Title:  Transfusion     Volume:  -     ISSN:  1537-2995     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 American Association of Blood Banks.
Affiliation:
From the Servicio de Hematología, Hospital Universitario de Salamanca; the Centro en Red de Medicina Regenerativa y Terapia Celular de Castilla y León; and the Centro de Investigación del Cáncer-IBMCC (Universidad de Salamanca-CSIC), Salamanca, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepcidin expression in patients with acute leukaemia.
Next Document:  Blockade of kinin B(1) receptor reverses plasma fatty acids composition changes and body and tissue...